Goldman Sachs’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Buy |
227,442
+115,457
| +103% | +$126K | ﹤0.01% | 4621 |
|
|
2025
Q1 | $109K | Sell |
111,985
-29,845
| -21% | -$29K | ﹤0.01% | 4805 |
|
|
2024
Q4 | $210K | Buy |
141,830
+26,689
| +23% | +$39.5K | ﹤0.01% | 4649 |
|
|
2024
Q3 | $244K | Buy |
115,141
+63,052
| +121% | +$134K | ﹤0.01% | 4422 |
|
|
2024
Q2 | $127K | Sell |
52,089
-120,705
| -70% | -$295K | ﹤0.01% | 4467 |
|
|
2024
Q1 | $1.12M | Buy |
+172,794
| New | +$1.12M | ﹤0.01% | 3546 |
|
|
2022
Q3 | – | Sell |
-10,983
| Closed | -$45K | – | 5560 |
|
|
2022
Q2 | $45K | Sell |
10,983
-672
| -6% | -$2.75K | ﹤0.01% | 5301 |
|
|
2022
Q1 | $51K | Buy |
11,655
+1,575
| +16% | +$6.89K | ﹤0.01% | 5467 |
|
|
2021
Q4 | $120K | Buy |
+10,080
| New | +$120K | ﹤0.01% | 5176 |
|
|
2021
Q3 | – | Sell |
-37,435
| Closed | -$653K | – | 5418 |
|
|
2021
Q2 | $653K | Buy |
+37,435
| New | +$653K | ﹤0.01% | 4278 |
|